Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

The 16th January saw the first liver randomised in Barcelona in the WP2 Liver Trial! It was randomised to Normothermic Machine Perfusion arm and a member of the Consortium is currently in Barcelona with the team to take them out on this first machine procedure.

Exciting times ahead as there are now three active WP2 partners: UK, Leuven, Barcelona.

The final partner to go live, Essen, will receive the machine delivery next week.

For more information on this cutting edge trial visit the COPE website: www.cope-eu.org

Similar stories

ARTICULATE PRO study releases new videos about the role of AI in prostate cancer diagnosis

The ARTICULATE PRO study at the Nuffield Department of Surgical Sciences (NDS) has produced three videos highlighting the use of artificial intelligence (AI) to help pathologists in diagnosing prostate cancer.